Diagnosis. Activation of systemic lupus erythematosus with cerebritis following pegylated interferon therapy. Management. Intravenous fluid, intermittent oxygen, intravenous diphenylhydantoin ...

The lessons learned with Benlysta also bode well for others developing lupus therapies, as the biotech seems to have finally figured out what it takes to design and conduct a successful trial in ...

GlaxoSmithKline’s Benlysta has been on the market for almost a decade, but it still has some tricks up its sleeve – it’s just become the first and only FDA-approved treatment for lupus ...

It is also planning a late-stage study in lupus nephritis in a bid to match Benlysta, as well as trials in cutaneous lupus erythematosus and myositis. President Trump's pick to lead the FDA ...

These include GSK’s Benlysta (belimumab) and AstraZeneca’s Saphnelo (anifrolumab). The market for CLE, however, has seen even less innovation. CLE is a form of lupus that primarily affects the ...